References
- Armstrong PJ, Bersten A. Normeperidine toxicity. Anesth Analg 1986; 65: 536–538
- Clark RF, Wei EM, Anderson PO. Meperidine: therapeutic use and toxicity. J Emerg Med 1995; 13: 797–802
- Goetting MG, Thirman MJ. Neurotoxicity of meperidine. Ann Emerg Med 1985; 14: 1007–1009
- Knight B, Thomson N, Perry G. Seizures due to norpethidine toxicity. Aust NZJ Med 2000; 30: 513
- Stone PA, Macintyre PE, Jarvis DA. Norpethidine toxicity and patient controlled analgesia. Br J Anaesth 1993; 71: 738–740
- Eisendrath SJ, Goldman B, Douglas J, Dimatteo L, Van Dyke C. Meperidine-induced delirium. Am J Psychiatry 1987; 144: 1062–1065
- Mather LE, Meffin PJ. Clinical pharmacokinetics of pethidine. Clin Pharmacokinet 1978; 3: 352–368
- Balestrero LM, Beaver CR, Rigas JR. Hypertensive crisis following meperidine administration and chemoembolization of a carcinoid tumor. Arch Intern Med 2000; 160: 2394–2395
- Szeto HH, Inturrisi CE, Houde R, Saal S, Cheigh J, Reidenberg MM. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer. Ann Intern Med 1977; 86: 738–741
- Kaiko RF, Foley KM, Grabinski PY, Heidrich G, Rogers AG, Inturrisi CE, Reidenberg MM. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983; 13: 180–185